Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029753485> ?p ?o ?g. }
- W2029753485 endingPage "E73" @default.
- W2029753485 startingPage "E66" @default.
- W2029753485 abstract "The standard treatment for patients with advanced gastric cancer (AGC) is still debated, and the available data on the benefit of irinotecan-containing regimen as first-line treatment for those patients are controversial. We performed a systematic review and meta-analysis of randomized controlled trials to determine the survival benefits of irinotecan-containing regimens in this setting. A total of 1,837 patients from ten trials were included in the analysis. Our results showed that irinotecan-containing regimens significantly improved overall survival [OS: hazard ratio (HR) 0.86, 95% CI = 0.78–0.94, p = 0.002] and progression-free survival [HR = 0.82, 95% CI = 0.69–0.97, p = 0.026); however, the improvement of time to failure (HR = 0.90; 95% CI = 0.77–1.04, p = 0.15), 1-year survival rate [1-year SR: relative risk (RR) 1.10, 95% CI = 0.97–1.24, p = 0.13] and overall response rate (RR = 1.16, 95% CI = 0.91–1.49, p = 0.24] were nonsignificant. Equivalent frequencies of toxicities were found between the two groups excluding more Grade 3 or 4 fatigue (p = 0.001) in irinotecan-containing regimens. This updated meta-analysis provided strong evidence for a survival benefit of irinotecan-containing regimen as first-line treatment for AGC. A clear advantage of irinotecan-containing over nonirinotecan-containing regimen had not been established. These results should help to inform decisions about patient management and design of future trials." @default.
- W2029753485 created "2016-06-24" @default.
- W2029753485 creator A5003816686 @default.
- W2029753485 creator A5004597656 @default.
- W2029753485 creator A5029153524 @default.
- W2029753485 creator A5035263099 @default.
- W2029753485 creator A5056438877 @default.
- W2029753485 creator A5059865856 @default.
- W2029753485 creator A5068938480 @default.
- W2029753485 creator A5089019392 @default.
- W2029753485 date "2012-09-01" @default.
- W2029753485 modified "2023-09-28" @default.
- W2029753485 title "Overall survival benefits for irinotecan-containing regimens as first-line treatment for advanced gastric cancer: An updated meta-analysis of ten randomized controlled trials" @default.
- W2029753485 cites W1944693814 @default.
- W2029753485 cites W1964435302 @default.
- W2029753485 cites W1966953116 @default.
- W2029753485 cites W1971329870 @default.
- W2029753485 cites W1972204979 @default.
- W2029753485 cites W1976841572 @default.
- W2029753485 cites W1983613881 @default.
- W2029753485 cites W2000330957 @default.
- W2029753485 cites W2002748327 @default.
- W2029753485 cites W2012792853 @default.
- W2029753485 cites W2015826015 @default.
- W2029753485 cites W2020830322 @default.
- W2029753485 cites W2024114545 @default.
- W2029753485 cites W2051318720 @default.
- W2029753485 cites W2053144686 @default.
- W2029753485 cites W2057550630 @default.
- W2029753485 cites W2063900267 @default.
- W2029753485 cites W2074152831 @default.
- W2029753485 cites W2075642745 @default.
- W2029753485 cites W2084212221 @default.
- W2029753485 cites W2095818357 @default.
- W2029753485 cites W2096139576 @default.
- W2029753485 cites W2103892569 @default.
- W2029753485 cites W2104709039 @default.
- W2029753485 cites W2106787323 @default.
- W2029753485 cites W2111689012 @default.
- W2029753485 cites W2131212105 @default.
- W2029753485 cites W2134338262 @default.
- W2029753485 cites W2145390243 @default.
- W2029753485 cites W2164411042 @default.
- W2029753485 cites W2164832531 @default.
- W2029753485 cites W2168127538 @default.
- W2029753485 cites W2168544170 @default.
- W2029753485 cites W2222808962 @default.
- W2029753485 cites W2314888238 @default.
- W2029753485 cites W2560123063 @default.
- W2029753485 doi "https://doi.org/10.1002/ijc.27775" @default.
- W2029753485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22890856" @default.
- W2029753485 hasPublicationYear "2012" @default.
- W2029753485 type Work @default.
- W2029753485 sameAs 2029753485 @default.
- W2029753485 citedByCount "10" @default.
- W2029753485 countsByYear W20297534852013 @default.
- W2029753485 countsByYear W20297534852014 @default.
- W2029753485 countsByYear W20297534852015 @default.
- W2029753485 countsByYear W20297534852016 @default.
- W2029753485 countsByYear W20297534852019 @default.
- W2029753485 crossrefType "journal-article" @default.
- W2029753485 hasAuthorship W2029753485A5003816686 @default.
- W2029753485 hasAuthorship W2029753485A5004597656 @default.
- W2029753485 hasAuthorship W2029753485A5029153524 @default.
- W2029753485 hasAuthorship W2029753485A5035263099 @default.
- W2029753485 hasAuthorship W2029753485A5056438877 @default.
- W2029753485 hasAuthorship W2029753485A5059865856 @default.
- W2029753485 hasAuthorship W2029753485A5068938480 @default.
- W2029753485 hasAuthorship W2029753485A5089019392 @default.
- W2029753485 hasConcept C121608353 @default.
- W2029753485 hasConcept C126322002 @default.
- W2029753485 hasConcept C141071460 @default.
- W2029753485 hasConcept C143998085 @default.
- W2029753485 hasConcept C168563851 @default.
- W2029753485 hasConcept C187960798 @default.
- W2029753485 hasConcept C207103383 @default.
- W2029753485 hasConcept C2780259306 @default.
- W2029753485 hasConcept C2781413609 @default.
- W2029753485 hasConcept C44249647 @default.
- W2029753485 hasConcept C526805850 @default.
- W2029753485 hasConcept C71924100 @default.
- W2029753485 hasConcept C82789193 @default.
- W2029753485 hasConcept C95190672 @default.
- W2029753485 hasConceptScore W2029753485C121608353 @default.
- W2029753485 hasConceptScore W2029753485C126322002 @default.
- W2029753485 hasConceptScore W2029753485C141071460 @default.
- W2029753485 hasConceptScore W2029753485C143998085 @default.
- W2029753485 hasConceptScore W2029753485C168563851 @default.
- W2029753485 hasConceptScore W2029753485C187960798 @default.
- W2029753485 hasConceptScore W2029753485C207103383 @default.
- W2029753485 hasConceptScore W2029753485C2780259306 @default.
- W2029753485 hasConceptScore W2029753485C2781413609 @default.
- W2029753485 hasConceptScore W2029753485C44249647 @default.
- W2029753485 hasConceptScore W2029753485C526805850 @default.
- W2029753485 hasConceptScore W2029753485C71924100 @default.
- W2029753485 hasConceptScore W2029753485C82789193 @default.
- W2029753485 hasConceptScore W2029753485C95190672 @default.
- W2029753485 hasIssue "2" @default.